Trump’s FDA Cuts Are Putting Drug Development at Riskby AI Generated Robotic Contentin AI/ML Newson Posted on March 4, 2025New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.Share this article with your network:TwitterFacebookRedditLinkedInEmailLike this:Like Loading...